Jardiance 10 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26F73AU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $45,795
Award facts
- Contract value 100% obligated
- $45,795.33 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $45,795.33 delivery order to AmerisourceBergen Drug Corp for 90-count tablets of Jardiance 10 mg, a pharmaceutical treatment for type 2 diabetes. The contract was awarded on December 12, 2025, under a firm fixed-price arrangement with an ultimate completion date of December 15, 2025. This delivery order represents a non-competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, with the performance location also in Conshohocken.
This award exemplifies AmerisourceBergen's role as a primary vendor within the Defense Logistics Agency's Medical Supply Chain, fulfilling pharmaceutical needs across military and veteran healthcare systems. The company's comprehensive pharmaceutical portfolio under the SPE2DX contract encompasses brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The firm fixed-price delivery order structure, combined with the company's established prime contract vehicle, enables efficient procurement of essential medications for federal healthcare operations. AmerisourceBergen's extensive track record of competitive awards and substantial contract values demonstrates its capability to meet federal medical supply requirements.
Quick answers
Who was awarded contract SPE2DR26F73AU?
SPE2DR26F73AU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 12, 2025.
How much is contract SPE2DR26F73AU worth?
The government has obligated $45,795 on SPE2DR26F73AU.
Is contract SPE2DR26F73AU an order under another contract?
Yes. SPE2DR26F73AU is a delivery order under SPE2DR25D1202, an indefinite delivery contract.
Was contract SPE2DR26F73AU competed?
The extent of competition for SPE2DR26F73AU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award